Impact Partnership Wealth LLC purchased a new position in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 11,850 shares of the company’s stock, valued at approximately $562,000.
A number of other hedge funds have also recently bought and sold shares of the company. GraniteShares Advisors LLC grew its position in shares of Docusign by 6.7% in the first quarter. GraniteShares Advisors LLC now owns 7,455 shares of the company’s stock valued at $353,000 after purchasing an additional 469 shares during the period. SJS Investment Consulting Inc. grew its holdings in Docusign by 160.6% in the 1st quarter. SJS Investment Consulting Inc. now owns 1,613 shares of the company’s stock valued at $76,000 after buying an additional 994 shares during the period. Tred Avon Family Wealth LLC increased its stake in shares of Docusign by 3.6% during the 1st quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company’s stock valued at $293,000 after acquiring an additional 215 shares during the last quarter. Formidable Asset Management LLC lifted its holdings in shares of Docusign by 51.5% during the 1st quarter. Formidable Asset Management LLC now owns 7,385 shares of the company’s stock worth $350,000 after acquiring an additional 2,510 shares during the period. Finally, Janney Montgomery Scott LLC boosted its position in shares of Docusign by 116.8% in the first quarter. Janney Montgomery Scott LLC now owns 30,796 shares of the company’s stock worth $1,460,000 after acquiring an additional 16,591 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
More Docusign News
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Zacks Research raised its FY2027 EPS estimate for Docusign to $1.69 from $1.53, suggesting stronger expected profitability over the next couple of years.
- Positive Sentiment: The firm also increased its FY2028 EPS estimate to $1.76 from $1.89, and lifted Q1 2028 EPS to $0.47 from $0.45, reinforcing a more favorable near-to-midterm earnings view.
- Positive Sentiment: Analysts boosted Q4 2028 EPS to $0.62 from $0.59 and Q1 2029 EPS to $0.73 from $0.51, indicating continued expectation for earnings growth further out. Docusign estimate revisions
- Neutral Sentiment: Not all revisions were positive: Zacks trimmed Q2 2028 EPS to $0.28 from $0.43, Q3 2028 EPS to $0.38 from $0.41, and FY2029 EPS to $1.35 from $2.10, showing a mixed long-range outlook.
- Neutral Sentiment: The current-year consensus estimate remains around $1.97 per share, so the latest changes mainly affect longer-dated forecasts rather than near-term results.
Docusign Trading Up 3.6%
Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.99 by $0.10. The firm had revenue of $830.24 million during the quarter, compared to the consensus estimate of $824.71 million. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.90 EPS. Equities research analysts expect that Docusign Inc. will post 2.03 EPS for the current fiscal year.
Docusign declared that its board has authorized a share repurchase plan on Tuesday, March 17th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to purchase up to 21% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its stock is undervalued.
Wall Street Analysts Forecast Growth
DOCU has been the subject of several research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a research report on Friday, June 5th. Weiss Ratings downgraded Docusign from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, June 26th. Wall Street Zen raised Docusign from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 13th. Robert W. Baird lowered their price target on Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Finally, Citizens Jmp cut their price objective on Docusign from $124.00 to $86.00 and set a “market outperform” rating on the stock in a report on Wednesday, March 18th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Docusign presently has an average rating of “Hold” and an average price target of $60.27.
Check Out Our Latest Stock Analysis on DOCU
Insider Activity
In other news, CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total transaction of $273,240.00. Following the transaction, the executive directly owned 89,972 shares of the company’s stock, valued at approximately $4,097,324.88. The trade was a 6.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Blake Jeffrey Grayson sold 15,000 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $45.55, for a total transaction of $683,250.00. Following the completion of the transaction, the chief financial officer owned 141,429 shares of the company’s stock, valued at $6,442,090.95. This trade represents a 9.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 76,695 shares of company stock worth $3,476,002 in the last ninety days. 0.59% of the stock is currently owned by company insiders.
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Featured Articles
- Five stocks we like better than Docusign
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
